Neuronetics STIM
NASDAQ STIM
$2.16 -0.06 (-2.70%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neuronetics (STIM) Gains from Sales and Divestitures (2025 - 2026)

Updated

Neuronetics (STIM) posted Gains from Sales and Divestitures of -$99,000 for Q2 2026.

Analysis

Neuronetics (STIM) Gains from Sales and Divestitures (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gains from Sales and Divestitures at Neuronetics was -$398,000; for FY2025, it was -$72,000.

  • In prior years, Neuronetics' Gains from Sales and Divestitures was -$28,000 in FY2024.
  • Quarterly Gains from Sales and Divestitures has run from a low of -$270,000 in Q1 2026 to a high of -$2,000 in Q3 2025 over five years.
  • According to Business Quant data, Gains from Sales and Divestitures for the three prior quarters was -$270,000 (Q1 2026), -$27,000 (Q4 2025) and -$2,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Neuronetics 164.58 Mn 79.82 Mn 21.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -99,000.00
Mar 31, 2026 -270,000.00
Dec 31, 2025 -27,000.00
Sep 30, 2025 -2,000.00
API Access

Neuronetics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=STIM&period=max&api_key=YOUR_API_KEY